T5	Subject 0 61	A female patient with HER2 positive, metastatic breast cancer
T8	Treatment 155 166	trastuzumab
T7	Effect 77 130	pulmonary infiltrates, and a plural effusion dyspnoea
T9	Gender 2 8	female
T10	Sub-Disorder 22 61	HER2 positive, metastatic breast cancer
T11	Drug 155 166	trastuzumab
T12	Time_elapsed 137 151	several months
